Elhan Webb
Investor Relations Kontakt bei KARYOPHARM THERAPEUTICS INC.
Aktive Positionen von Elhan Webb
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KARYOPHARM THERAPEUTICS INC. | Investor Relations Kontakt | 14.03.2022 | - |
Karriereverlauf von Elhan Webb
Ehemalige bekannte Positionen von Elhan Webb
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ROCHE HOLDING AG | Public Communications Contact | - | - |
RUBIUS THERAPEUTICS | Investor Relations Kontakt | 01.11.2020 | - |
RADIUS HEALTH, INC. | Investor Relations Kontakt | 02.01.2018 | - |
Public Communications Contact | 02.01.2018 | - |
Ausbildung von Elhan Webb
University of Southern California | Masters Business Admin |
Bogazici University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Türkei | 2 |
Operativ
Investor Relations Contact | 3 |
Public Communications Contact | 2 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Börse
- Insiders
- Elhan Webb
- Erfahrung